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Purpose: Lower extremity amputation (LEA) is associated with a high risk of postoperative
mortality. The effect of type of anesthesia on postoperative mortality has been studied in
various surgeries. However, data for guiding the selection of optimal anesthesia for LEA are
limited. This study aimed to determine the effect of anesthesia type on perioperative out-
comes in patients with diabetes and/or peripheral vascular disease undergoing LEA.
Patients and methods: We reviewed the medical records of patients who underwent LEA
at our center between September 2007 and August 2017, who were grouped according to use
of general anesthesia (GA) or regional anesthesia (RA). Primary outcomes were 30-day and
90-day mortality. Secondary outcomes were postoperative morbidity, intraoperative events,
postoperative intensive care unit admission, and postoperative length of stay. Propensity
score-matched cohort design was used to control for potentially confounding factors, includ-
ing patient demographics, comorbidities, medications, and type of surgery.
Results: Five hundred and nineteen patients (75% male, mean age 65 years) were identiﬁed to
have received GA (n=227) or RA (n=292) for above-knee amputation (1.5%), below-knee
amputation (16%), or more minor amputation (82.5%). Before propensity score matching,
there was an association of GA with coronary artery disease (44% [GA] vs 34.5% [RA],
p=0.028), peripheral arterial disease (73.1% vs 60.2%, p=0.002), and preoperative treatment
with aspirin and clopidogrel (68.7% vs 55.1%, p=0.001; 63% vs 41.8%, p<0.001, respectively).
Propensity score matching produced a cohort of 342 patients equally divided between GA and
RA. There was no signiﬁcant between-group difference in 30-day (3.5% vs 2.9%, p=0.737) or
90-day (6.4% vs 4.6%, p=0.474) mortality or postoperative morbidity. However, postoperative
ICU admission (14.6% vs 7%, p=0.032), intraoperative hypotension (61.4% vs 14.6%, p<0.001),
and vasopressor use (52% vs 14%, p<0.001) were more common with GA than with RA.
Conclusion: Type of anesthesia did not signiﬁcantly affect mortality or morbidity after
LEA. However, intraoperative hypotension, vasopressor use, and postoperative ICU admis-
sion rates were lower with RA.
Keywords: lower extremity amputation, diabetes, peripheral vascular disease, type of
anesthesia, mortality, morbidity
Introduction
Diabetes and peripheral vascular disease are the leading causes of lower extremity
amputation (LEA). LEA is a commonly performed procedure that is indicated in
patients with failed attempts at revascularization, comorbidity or anatomic factors
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precluding revascularization efforts, and extensive tissue
loss or infection.1 Patients who undergo LEA usually have
comorbidities, including hypertension, heart failure, and
end-stage renal disease, and are likely to be in an older
age group. Furthermore, these patients have advanced
systemic atherosclerotic disease involving not only the
peripheral limbs but also the coronary, cerebral, and
renal circulations.2 The incidence of coronary artery dis-
ease in patients with peripheral artery disease who require
LEA is estimated to be as high as 80%,3 and some receive
interventional treatment before surgery and ongoing dual
antiplatelet therapy. These patients are at high periopera-
tive risk, so the anesthesiologist needs to choose the
appropriate anesthetic method carefully.
Theoretically, regional anesthesia (RA) offers several
advantages over general anesthesia (GA). A previous study
has demonstrated advantages of RA in procedures involving
a lower extremity, including fewer pulmonary complications,
a decreased risk of arterial or venous thrombosis, avoidance
of mechanical ventilation, and a reduced requirement for
blood transfusion.4 Compared with GA, neuraxial anesthesia,
in particular, has been associatedwith lower 30-daymortality
and decreased morbidity, less blood loss, fewer surgical site
infections, and a decreased rate of admission to critical care
services after elective total hip or knee arthroplasty.5
It is well established that LEA secondary to diabetes
and/or peripheral vascular disease has a high perioperative
mortality rate.6 Postoperative 30-day mortality rates after
LEA have been reported to be between 7% and 22%.7
According to previous studies,8–11 advanced age, depen-
dent functional status, proximal (eg, above-knee) amputa-
tion, a history of cardiac disease, chronic renal disease,
preoperative sepsis, and use of steroids are associated with
postoperative mortality. However, although there have
been several recent reports on the effect of anesthetic
methods on postoperative outcome in patients with LEA,
no clear consensus has been established.
The purpose of this retrospective, propensity score-
matched cohort study was to analyze the effect of type of
anesthesia on postoperative mortality and morbidity in
patients undergoing LEA because of diabetes and/or per-
ipheral vascular disease.
Materials And Methods
Study Population
The study protocol was approved by the institutional review
board (IRB) of Severance Hospital, Yonsei University Health
System (IRB No. 4-2017-0979) and carried out in accor-
dance with the rules of the Declaration of Helsinki of 1975.
The patient records and information were anonymized before
analysis, so the requirement for written informed consent to
access medical records was waived. We retrospectively iden-
tiﬁed all patients who underwent LEA because of diabetic
foot or peripheral vascular disease at Severance Hospital
between September 30, 2007 and August 31, 2017. The
LEAs included both major (above-knee and below-knee)
and minor (distal to below-knee) amputations. The exclusion
criteria were age under 20 years at the time of surgery,
amputation secondary to trauma or malignancy, and LEA
performed with concomitant surgery. Patients with incom-
plete medical records, those who were lost to follow-up, and
those undergoing RA that was converted to GA were
excluded.
The study population was divided into 2 groups based
on anesthesia modality, ie, a GA group and an RA group.
GA consisted of endotracheal intubation or use of a lar-
yngeal mask airway with a combination of inhalational
anesthetics and intravenous narcotics for maintenance of
anesthesia. RA was deﬁned as spinal anesthesia or periph-
eral nerve block with or without sedation.
Study Objectives
The primary study outcome was 30-day and 90-day mortal-
ity. The secondary outcomes were postoperative length of
stay, need for admission to the postoperative intensive care
unit (ICU), 90-day morbidity, and intraoperative events.
Patient Demographics And Perioperative
Variables
Standard demographic data, including age, sex, and bodymass
index, as well as American Society of Anesthesiologists phy-
sical status classiﬁcation were obtained for all patients. Data
on comorbidities were also collected, including history of
diabetes, hypertension, coronary artery disease, peripheral
artery disease, congestive heart failure, cerebrovascular acci-
dent, chronic kidney disease, chronic obstructive pulmonary
disease, and smoking history. Preoperative use of aspirin,
clopidogrel, steroids, insulin, and statins was also recorded.
Preoperative laboratory data included hemoglobin, platelets,
prothrombin time, activated partial thromboplastin time, glu-
cose, glycated hemoglobin, creatinine, estimated glomerular
ﬁltration rate, albumin, and C-reactive protein. The type of
surgery (ie, amputation level), operating time, and anesthesia
time were recorded. Information on intraoperative events,
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such as presence of hypoxia or hypotension, use of a vaso-
pressor (ie, ephedrine, phenylephrine, norepinephrine, or vaso-
pressin), and transfusion of blood products, were obtained.
The postoperative variables included death, cardiovascular,
pulmonary, renal, and neurologic complications, sepsis, and
wound healing complications. Postoperative admission to the
ICU and postoperative length of stay were also assessed.
Statistical Analysis
We used a propensity score-matched cohort design to
control for potentially confounding factors. This type of
design is intended to mimic a randomized trial by selecting
comparison cohorts that are similar in regard to the prob-
ability, or “propensity,” of receiving the intervention (GA
or RA) under study.12 In this model, the type of anesthesia
was used as the dependent variable. The independent
variables were those identiﬁed in earlier studies as being
signiﬁcant in terms of study outcomes as well as those that
might, in the opinion of the authors, make a contribution.
Propensity scoring was based on the model and included
patient demographics (age, sex, and body mass index),
comorbidities (diabetes, hypertension, coronary artery dis-
ease, peripheral artery disease, congestive heart failure,
cerebrovascular accident, chronic kidney disease, chronic
obstructive pulmonary disease, and smoking history),
medications (aspirin, clopidogrel, steroid, insulin, and sta-
tin), and type of surgery. We then matched each case with
GA to a case with RA that had a similar propensity score;
1:1 propensity score matching was performed to match
patients with RA to controls within a caliper of 0.01. In
our matching algorithm, we performed 1:1 nearest neigh-
bor matching.
For unmatched data, the Student’s t-test or Mann–
Whitney U-test were used for continuous variables and
the Pearson’s chi-squared test or Fisher’s exact test for
categorical variables. After matching, the Mann–Whitney
U-test was used to analyze the continuous variables and
McNemar’s test to assess the categorical variables. We
used stratiﬁed Cox proportional hazards modeling to com-
pare the risk of postoperative mortality in the different
anesthetic groups. The risk was expressed by hazard ratios
(HRs) with corresponding 95% conﬁdence intervals (CIs).
Conditional logistic regression models were used to com-
pare secondary outcomes within each group. The effect
was expressed by odds ratios (ORs) with corresponding
95% CIs.
The statistical analyses were performed using SAS (ver-
sion 9.4; SAS Institute Inc., Cary, NC, USA) and IBM SPSS
Statistics for Windows (version 23; IBM Corp., Armonk,
NY, USA). A p-value <0.05 was considered statistically
signiﬁcant.
Results
In total, 1152 patients underwent LEA at Severance
Hospital between September 30, 2007 and August 31,
2017. After application of the exclusion criteria, data for
519 patients were available for inclusion in the ﬁnal analy-
sis. The mean age at the time of surgery was 65 years, and
72% of the patients were male. Eight patients (1.5%) under-
went above-knee amputation, 83 (16%) underwent below-
knee amputation, and 428 (82.5%) underwent more minor
amputation. There were 227 patients in the GA group and
292 in the RA group. In the RA group, 239 patients received
spinal anesthesia and 53 received a peripheral nerve block.
The study ﬂow chart is shown in Figure 1.
The baseline patient characteristics, comorbidities, use
of medication, surgical details, and preoperative laboratory
data are presented in Table 1. Patients with coronary or
peripheral artery disease were more likely to receive GA
than RA (44.1% vs 34.6%, p=0.028 and 73.1% vs 60.3%,
p=0.002, respectively). There were no statistically signiﬁ-
cant between-group differences in the proportions of
patients with diabetes, hypertension, congestive heart fail-
ure, cerebrovascular accident, chronic kidney disease, or
Figure 1 Consort diagram.
Abbreviations: LEA, lower extremity amputation; GA, general anesthesia; RA,
regional anesthesia.
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chronic obstructive pulmonary disease, or according to
smoking history. Patients who were receiving antiplatelet
therapy, such as aspirin and clopidogrel, preoperatively
were more likely to receive GA than RA (68.7% vs
55.1%, p=0.001 and 63% vs 41.8%, p<0.001, respectively).
The GA group had lower preoperative hemoglobin and
albumin values and higher preoperative platelet, prothrom-
bin time, and C-reactive protein values. Major (ie, above-
knee or below-knee) amputation was signiﬁcantly more
common in the GA group than in the RA group (23.8% vs
12.7%, p=0.001) and the operating and anesthesia times
were longer in the GA group (72 mins vs 54.1 mins,
p<0.001 and 115.7 mins vs 88.2 mins, p<0.001, respec-
tively). Appropriate propensity score matching produced
171 matched pairs (342 patients, comprising 65.9% of the
total study population) with exclusion of 177 cases (56 with
GA and 122 with RA). There was no signiﬁcant difference
in baseline characteristics, comorbidities, use of medica-
tion, or type of operation in the matched study population
(Table 2). However, the operating and anesthesia times
were signiﬁcantly longer in the GA group than in the RA
group (69.5 mins vs 58.5 mins, p=0.019 and 112.3 mins vs
93.1 mins, p<0.001, respectively). The preoperative platelet
and C-reactive protein values were signiﬁcantly higher in
the GA group than in the RA group (344 vs 312.6, p=0.038
and 104 vs 68.6, p<0.001, respectively).
In the propensity-score matched cohort, there was no
statistically signiﬁcant difference in the primary outcome
of 30-day and 90-day mortality between the two groups
(3.5% for GA vs 2.9% for RA, HR 0.83, 95% CI 0.28–
2.46, p=0.73, 7 and 6.4% for GA vs 4.6% for RA, HR
Table 1 Baseline Demographic And Clinical Characteristics Of
Patients Undergoing Lower Limb Amputation According To Type
Of Anesthesia
Variable GA Group
(n=227)
RA Group
(n=292)
p-Value
Age (years) 66 (56, 73) 65 (57, 73) 0.986
Male 168 (74%) 222 (76%) 0.597
Body mass index (kg/m2) 23 (20.4,
25.5)
22.6 (20.3,
24.9)
0.372
Comorbidity
Hypertension 183 (80.6%) 220 (75.3%) 0.152
Diabetes 202 (89%) 267 (91.4%) 0.347
CAD 100 (44.1%) 101 (34.6%) 0.028*
PAD 166 (73.1%) 176 (60.3%) 0.002*
Congestive heart failure 11 (4.9%) 26 (8.9%) 0.074
Cerebrovascular
accident
52 (22.9%) 49 (16.8%) 0.080
Chronic kidney disease 105 (46.3%) 148 (50.7%) 0.316
COPD 5 (2.2%) 11 (3.8%) 0.306
Positive smoking
history
69 (30.4%) 108 (37%) 0.116
Medication
Aspirin 156 (68.7%) 161 (55.1%) 0.001*
Clopidogrel 143 (63%) 122 (41.8%) <0.001*
Steroid 17 (7.5%) 22 (7.5%) 0.984
Insulin 87 (38.3%) 114 (39%) 0.868
Statin 94 (41.4%) 109 (37.3%) 0.344
Type of operation
Major amputation 54 (23.8%) 37 (12.7%) 0.001*
Above-knee
amputation
7 (3.1%) 1 (0.3%)
Below-knee
amputation
47 (20.7%) 36 (12.3%)
Minor amputation 173 (76.2%) 255 (87.3%)
Operating time (min) 72 ± 47.5 54.1 ± 35 <0.001*
Anesthesia time (min) 115.7 ± 53.5 88.2 ± 41.8 <0.001*
ASA physical status classiﬁcation
2 32 (14.1%) 53 (18.2%) 0.346
3 138 (60.8%) 177 (60.6%)
4 57 (25.1%) 62 (21.2%)
Preoperative laboratory data
Hemoglobin (g/dL) 10.1 ± 1.7 10.5 ± 1.8 0.010*
Platelet count (103/μL) 339.2 ± 137 302.5 ± 126 0.002*
Prothrombin time (%) 12.9 ± 2.9 12.1 ± 2.1 0.003*
aPTT (s) 33.1 ± 8.2 32.7 ± 9.2 0.677
Glycated hemoglobin
(%)
7.4 ± 2.8 7.3 ± 2.7 0.884
(Continued)
Table 1 (Continued).
Variable GA Group
(n=227)
RA Group
(n=292)
p-Value
Glucose (mg/dL) 157.5 ± 81.6 166.5 ±
101.3
0.279
Creatinine (mg/dL) 3.2 ± 12.2 2.4 ± 2.6 0.302
eGFR (mL/min/1.73 m2) 57 ± 36.2 55.9 ± 33.6 0.723
Albumin (g/dL) 3.0 ± 0.7 3.3 ± 0.6 <0.001*
C-reactive protein
(mg/dL)
108.5 ± 96.2 68.8 ± 80.8 <0.001*
Notes: Categorical data are presented as the number (percentage) and continuous
data as the mean ± standard deviation or median (IQR [range]). *Signiﬁcantly
different.
Abbreviations: aPTT, activated partial thromboplastin time; ASA, American
Society of Anesthesiologists; CAD, coronary artery disease; COPD, chronic
obstructive pulmonary disease; eGFR, estimated glomerular ﬁltration rate; GA,
general anesthesia; PAD, peripheral artery disease; RA, regional anesthesia.
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0.724, 95% CI 0.3–1.75, p=0.474; Figure 2, Table 3).
There was also no statistically signiﬁcant difference in
90-day postoperative morbidity, ie, myocardial infarction,
cardiac arrest, pneumonia, sepsis, renal failure, stroke, or
wound healing complications. There was no signiﬁcant
between-group difference in the postoperative length of
stay (10 days vs 10 days, p=0.24). However, when com-
pared with the GA group, the RA group had signiﬁcantly
lower rates of postoperative ICU admission (14.6% vs 7%,
OR 0.458, 95% CI 0.225–0.936, p=0.032), intraoperative
Table 2 Baseline Patient Demographic And Clinical Characteristics
After Propensity Score Matching
Variable GA Group
(n=171)
RA Group
(n=171)
p-Value
Age (years) 65 (55, 72) 66 (57, 73) 0.510
Male 123 (71.9%) 127 (74.3%) 0.617
Body mass index (kg/m2) 23.1 (20.7,
25.7)
22.6 (19.8,
24.8)
0.105
Comorbidity
Hypertension 137 (80.1%) 132 (77.2%) 0.522
Diabetes 154 (90.1%) 152 (88.9%) 0.723
CAD 72 (42.1%) 75 (43.9%) 0.758
PAD 113 (66.1%) 117 (68.4%) 0.658
Congestive heart failure 10 (5.9%) 8 (4.7%) 0.637
Cerebrovascular
accident
33 (19.3%) 34 (19.9%) 0.892
Chronic kidney disease 73 (42.7%) 91 (53.2%) 0.057
COPD 2 (1.2%) 4 (2.3%) 0.414
Smoking history 61 (35.7%) 62 (36.3%) 0.912
Medication
Aspirin 106 (62%) 109 (63.7%) 0.741
Clopidogrel 94 (55%) 101 (59%) 0.436
Steroid 14 (8.2%) 14 (8.25) >0.999
Insulin 67 (39.2%) 63 (36.8%) 0.637
Statin 71 (41.5%) 74 (43.3%) 0.744
Type of operation
Major amputation 29 (17%) 31 (18.1%) 0.777
Above-knee
amputation
2 (1.2%) 0 (0%)
Below-knee
amputation
27 (15.8%) 31 (18.1%)
Minor amputation 142 (83%) 140 (81.9%)
Operating time (min) 69.5 ± 48.5 58.5 ± 37.3 <0.019*
Anesthesia time (min) 112.3 ± 55 93.1 ± 44.6 <0.001*
ASA physical status classiﬁcation
2 26 (15.2%) 24 (14%) 0.950
3 106 (62%) 109 (63.7%)
4 39 (22.8%) 38 (22.3%)
Preoperative laboratory data
Hemoglobin (g/dL) 10.1 ± 1.8 10.2 ± 1.6 0.577
Platelet count (103/μL) 344 ± 137.4 312.6 ±
140.6
0.038*
Prothrombin time (%) 12.7 ± 2.7 12.3 ± 2.4 0.271
aPTT (s) 32.4 ± 7.1 33 ± 10.7 0.711
Glycated hemoglobin
(%)
8 ± 2.1 7.7 ± 1.9 0.220
Glucose (mg/dL) 156.8 ± 78.9 151 ± 88.7 0.522
(Continued)
Table 2 (Continued).
Variable GA Group
(n=171)
RA Group
(n=171)
p-Value
Creatinine (mg/dL) 2.3 ± 2.5 2.6 ± 2.8 0.230
eGFR (mL/min/1.73 m2) 58.6 ± 35.5 54 ± 34.5 0.220
Albumin (g/dL) 3.1 ± 0.7 3.1 ± 0.6 0.461
C-reactive protein
(mg/dL)
104 ± 97.2 68.6 ± 75.6 <0.001*
Notes: Categorical data are presented as the number (percentage) and continuous
data as the mean ± standard deviation or median (IQR [range]). *Signiﬁcantly
different.
Abbreviations: aPTT, activated partial thromboplastin time; ASA, American
Society of Anesthesiologists; CAD, coronary artery disease; COPD, chronic
obstructive pulmonary disease; eGFR, estimated glomerular ﬁltration rate; GA,
general anesthesia; PAD, peripheral artery disease; RA, regional anesthesia.
Figure 2 Kaplan–Meier 90-day mortality curve.
Note: The cumulative death rate in patients undergoing lower extremity amputa-
tion under general anesthesia (blue) or regional anesthesia (green).
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hypotension (61.4% vs 14.6%, OR 0.101, 95% CI 0.051–
0.201, p<0.001), and use of vasopressors (52% vs 14%,
OR 0.145, 95% CI 0.077–0.272, p<0.001; Tables 4 and 5).
Discussion
In this retrospective propensity-matched cohort study of
342 patients undergoing LEA because of diabetic foot
and/or peripheral vascular disease, we found no signiﬁcant
difference in 30-day or 90-day mortality between the
patients who received RA and those who received GA.
Furthermore, the method of anesthesia used did not affect
the likelihood of postoperative morbidity or the postopera-
tive length of stay. However, we found that patients who
underwent LEA under GAwere signiﬁcantly more likely to
develop intraoperative hypotension, require a vasopressor,
and be admitted to the ICU postoperatively.
RA, such as a neuraxial or peripheral nerve block, has a
number of theoretical advantages when compared with GA.
These include attenuation of the normal physiologic
response to stress with lower levels of circulating catecho-
lamines and cortisol, sympathetic blockade with resulting
peripheral vasodilation and increased blood ﬂow, decreased
hypercoagulability with a potentially lower incidence of
arterial and venous thrombosis, and the ability to avoid
endotracheal intubation and mechanical ventilation.13,14
The results of this study also showed that patients
undergoing LEA under RA were more hemodynamically
stable during surgery. Generally, changes in intraoperative
hemodynamics under GA are a response to cardiovascular
Table 3 Cox Regression Results For The Study Groups After Propensity Score Matching
Primary Outcome GA Group (n=171) RA Group (n=171) HR (95% CI) p-Value
30-Day mortality 6 (3.5%) 5 (2.9%) 0.830 (0.280, 2.461) 0.737
90-Day mortality 11 (6.4%) 8 (4.6%) 0.724 (0.300, 1.750) 0.474
Note: Categorical data are presented as the number (percentage).
Abbreviations: CI, conﬁdence interval; GA, general anesthesia; HR, hazard ratio; RA, regional anesthesia.
Table 4 Outcomes Data
Variable Total Population Propensity-Matched Population
GA Group
(n=227)
RA Group
(n=292)
p-Value GA Group
(n=171)
RA Group
(n=171)
p-Value
Morbidity
Myocardial infarction 8 (3.5%) 7 (2.4%) 0.447 4 (2.3%) 5 (2.9%) 0.738
Cardiac arrest 4 (1.8%) 11 (3.8%) 0.176 2 (1.2%) 7 (4.1%) 0.095
Pneumonia 21 (9.3%) 14 (4.8%) 0.044* 14 (8.2%) 9 (5.3%) 0.297
Postoperative intubation 10 (4.4%) 12 (4.1%) 0.868 3 (1.8%) 7 (4.1%) 0.205
MV >24 hrs 13 (5.7%) 11 (3.8%) 0.291 6 (3.5%) 7 (4.1%) 0.781
Sepsis 21 (9.3%) 9 (3.1%) 0.002* 14 (8.2%) 7 (4.1%) 0.126
Renal failure 20 (8.8%) 25 (8.6%) 0.92 14 (8.2%) 15 (8.8%) 0.847
Stroke 2 (0.9%) 4 (1.4%) 0.7 2 (1.2%) 4 (2.3%) 0.414
Wound healing cx 40 (17.6%) 53 (18.2%) 0.876 31 (18.1%) 34 (19.9%) 0.68
Postoperative ICU care 44 (19.4%) 18 (6.2%) <0.001* 25 (14.6%) 12 (7.0%) 0.019*
Intraoperative event
Transfusion 30 (13.2%) 15 (5.1%) 0.001* 22 (12.9%) 13 (7.6%) 0.106
Hypotension 138 (60.8%) 38 (13.0%) <0.001* 105 (61.4%) 25 (14.6%) <0.001*
Vasopressor usea 120 (52.9%) 36 (12.3%) <0.001* 89 (52.1%) 24 (14.0%) <0.001*
Hypoxia 1 (0.4%) 2 (0.7%) >0.999 0 (0%) 1 (0.6%) 0.317
Postoperative hospital stay
(days)
11 (6, 19) 9 (6, 14) 0.025* 10 (6, 19) 10 (6, 15) 0.240
Notes: Categorical data are presented as the number (percentage) and continuous data as the mean ± standard deviation or median (IQR [range]). aVasopressors included
ephedrine, phenylephrine, norepinephrine, and vasopressin. *Signiﬁcantly different.
Abbreviations: cx, complications; GA, general anesthesia; ICU, intensive care unit; MV, mechanical ventilation; RA, regional anesthesia.
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suppression and peripheral vasodilation by inhalation or
intravenous anesthetic agents. Patients who undergo LEA
may have cardiovascular comorbidity, such as coronary
artery disease, and may be more vulnerable to the systemic
effects of GA because of their decreased cardiopulmonary
reserve.15 Although there was no signiﬁcant difference in
the postoperative length of stay between the study groups,
patients who underwent GA were signiﬁcantly more likely
to be admitted to the ICU after surgery. This ﬁnding may
be explained by the greater likelihood of intraoperative
hemodynamic instability in patients undergoing GA and
their need for intensive monitoring after surgery.
However, the between-group differences in intraopera-
tive hemodynamics did not affect mortality or morbidity
after surgery. Although intraoperative hypotension was
more common in the GA group, there was no signiﬁcant
difference in postoperative cardiovascular morbidity, such
as cardiac arrest or myocardial infarction, between the two
study groups. Patients receiving RA avoided intubation or
mechanical ventilation during surgery, but without any
signiﬁcant increase in the risk of pulmonary morbidity,
such as pneumonia, postoperative intubation, or prolonged
mechanical ventilation. Furthermore, there was no signiﬁ-
cant difference in any of the other postoperative morbid-
ities, such as stroke, renal failure, sepsis, or wound healing
complications, according to anesthesia modality.
Many studies have been published on the effect of
anesthesia modality on the postoperative prognosis, com-
plication rate, and risk of mortality.16 Several studies in
total knee or hip arthroplasty and hip surgery have
reported that RA is more advantageous than GA in terms
of postoperative mortality and morbidity.5,17–20
Several retrospective studies have been published on the
effect of anesthesia technique on the postoperative outcome of
LEA, although their ﬁndings have been inconsistent.13,15,21
However, there was no difference in postoperative mortality
and morbidity in a recently published study that used a pro-
pensity score matching cohort.4,22,23 According to Moreira et
al, there was no difference in 30-day mortality or postopera-
tive morbidity according to anesthesia modality in a function-
ally impaired geriatric population receiving major LEA.22 In a
retrospective study of 9999 patients who underwent above-
knee amputation, Pisansky et al reported no difference in 30-
day mortality or cardiovascular, pulmonary, infectious, and
bleeding complications according to the method of anesthesia
used.23 More recently, Malik et al reported a retrospective
propensity score-matched review that included 12,723
patients who underwent below-knee amputation, in which
there was no statistically signiﬁcant difference in 30-day
mortality or major morbidity according to type of anesthesia
used.4 According toMalik et al, the incidence of perioperative
blood transfusion was low in the RA group.
Table 5 Results Of Logistic Regression Analysis Of Between-Group Differences After Propensity Score Matching
Variable GA Group (n=171) RA Group (n=171) OR (95% CI) p-Value
Morbidity
Myocardial infarction 4 (2.3%) 5 (3%) 1.25 (0.336, 4.655) 0.739
Cardiac arrest 2 (1.2%) 7 (4.1%) 3.5 (0.727, 16.848) 0.118
Pneumonia 14 (8.2%) 9 (5.3%) 0.583 (0.230, 1.482) 0.257
Postoperative intubation 3 (1.8%) 7 (4.1%) 2.333 (0.603, 9.023) 0.219
MV >24 hrs 6 (3.5%) 7 (4.1%) 1.167 (0.392, 3.471) 0.781
Sepsis 14 (8.2%) 7 (4.1%) 0.417 (0.147, 1.183) 0.100
Renal failure 14 (8.2%) 15 (8.8%) 1.083 (0.494, 2.374) 0.841
Stroke 2 (1.2%) 4 (2.3%) 2.00 (0.366, 10.919) 0.423
Wound healing complications 31 (18.1%) 34 (20%) 1.115 (0.657, 1.894) 0.686
Postoperative ICU admission 25 (14.6%) 12 (7%) 0.458 (0.225, 0.936) 0.032*
Intraoperative events
Hypotension 105 (61.4%) 25 (14.6%) 0.101 (0.051, 0.201) <0.001*
Vasopressor usea 89 (52.1%) 24 (14%) 0.145 (0.077, 0.272) <0.001*
Transfusion 22 (12.9%) 13 (7.6%) 0.50 (0.225, 1.113) 0.089
Hypoxia 0 (0%) 1 (0.6%) (–) (–)
Notes: Categorical data are presented as the number (percentage). Vasopressors included ephedrine, phenylephrine, norepinephrine, and vasopressin. *Signiﬁcantly
different.
Abbreviations: GA, general anesthesia; ICU, intensive care unit; MV, mechanical ventilation; RA, regional anesthesia.
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It is not clear why there is no signiﬁcant difference in
postoperative mortality or morbidity in the LEA popula-
tion according to the anesthetic method used. However,
the anesthesia modality selected for LEA has less of an
impact when compared with other surgical procedures, and
most patients who undergo LEA are high-risk patients
with multiple comorbidities.
This retrospective study included 519 patients who
underwent LEA performed by any of three orthopedic
surgeons over one decade at a single center. Therefore,
the perioperative management was consistent and the rele-
vant medical records were preserved in detail.
The 30-day mortality in this study was 3.5% in the GA
group, 2.9% in the RA group, and 3.2% overall. In a study
by Gurney et al, the 30-day mortality after minor amputa-
tion was 3%.24 We included patients who underwent major
or minor amputation, unlike previously reported studies
that only included patients who underwent major amputa-
tion. Therefore, the 30-day mortality rate in this study can
be considered relatively lower than the rate of 7–22% in
previous reports.7
This study has several limitations. First, it is a retro-
spective review of a large database, which has inherent
limitations. Second, although propensity score matching
was used to exclude the effects of variables other than
anesthesia modality as far as possible, the preoperative
CRP values were not consistent across the 2 cohorts,
which could have inﬂuenced our results. Furthermore,
the operating and anesthesia times and the preoperative
platelet values were not controlled; however, any differ-
ences were unlikely to be clinically signiﬁcant. Third,
other important clinical factors that may inﬂuence the
mode of anesthesia chosen, such as severe aortic stenosis,
presence of surgical site infection, and patient preference,
were not assessed. Finally, the high minor amputation rate
of 82.5% needs to be taken into consideration when inter-
preting the results of this study.
Conclusion
Our present ﬁndings suggest that anesthesia modality is not
an independent contributor to postoperative mortality or
morbidity in patients who undergo LEA. However, more
intraoperative hemodynamic changes may occur in patients
who undergo minor amputations under GA. Therefore, the
choice of anesthesia method should be determined by the
overall health status of the patient and the type of surgical
procedure and be selected carefully after communication
between the surgeon, anesthesiologist, and patient. It is also
important to identify and prepare for the patient’s comorbid-
ities and risk factors.
Disclosure
The authors report no conﬂicts of interest in this work.
References
1. Aulivola B, Hile CN, Hamdan AD, et al. Major lower extremity
amputation: outcome of a modern series. Arch Surg. 2004;139:395–
399. doi:10.1001/archsurg.139.4.395
2. Anton JM, McHesnry ML. Perioperative management of lower extre-
mity revascularization. Anesthesiol Clin. 2014;32:661–676. doi:10.
1016/j.anclin.2014.05.004
3. Abou-Zamzam AM Jr, Teruya TH, Killeen JD, Ballard JL. Major
lower extremity amputation in an academic vascular center. Ann Vasc
Surg. 2003;17:86–90. doi:10.1007/s10016-001-0340-0
4. Malik O, Brovman EY, Urman RD. The use of regional or neuraxial
anesthesia for below-knee amputations may reduce the need for
perioperative blood transfusions. Reg Anesth Pain Med.
2018;43:25–35. doi:10.1097/AAP.0000000000000687
5. Perlas A, Chan VWS, Beattie S. Anesthesia technique and mortality
after total hip or knee arthroplasty: a retrospective, propensity score-
matched cohort study. Anesthesiology. 2016;125:724–731. doi:10.1097/
ALN.0000000000001248
6. Stern JR, Wong CK, Yerovinkina M, et al. A meta-analysis of long-term
mortality and associated risk factors following lower extremity amputa-
tion. Ann Vasc Surg. 2017;42:322–327. doi:10.1016/j.avsg.2016.12.015
7. van Netten JJ, Fortington LV, Hinchliffe RJ, Hijmans JM. Early post-
operative mortality after major lower limb amputation: a systematic
review of population and regional based studies. Eur J Vasc
Endovasc Surg. 2016;51:248–258. doi:10.1016/j.ejvs.2015.10.001
8. Yamada K, Yasunaga H, Kadono Y, et al. Postoperative outcomes of
major lower extremity amputations in patients with diabetes and
peripheral artery disease: analysis using the diagnosis procedure
combination database in Japan. Am J Surg. 2016;212:446–450.
doi:10.1016/j.amjsurg.2015.08.039
9. Thorud JC, Plemmons B, Buckley CJ, Shibuya N, Jupiter DC.
Mortality after nontraumatic major amputation among patients with
diabetes and peripheral vascular disease: a systematic review. J Foot
Ankle Surg. 2016;55:591–599. doi:10.1053/j.jfas.2016.01.012
10. Easterlin MC, Chang DC, Wilson SE. A practical index to predict 30-
day mortality after major amputation. Ann Vasc Surg. 2013;27:909–
917. doi:10.1016/j.avsg.2012.06.030
11. Belmont PJ, Davey S, Orr JD, Ochoa LM, Bader JO, Schoenfeld AJ.
Risk factors for 30-day postoperative complications and mortality
after below-knee amputation: a study of 2,911 patients from the
national surgical quality improvement program. J Am Coll Surg.
2011;213:370–378. doi:10.1016/j.jamcollsurg.2011.05.019
12. Bulka CM, Shotwell MS, Gupta RK, Sandberg WS, Ehrenfeld JM.
Regional anesthesia, time to hospital discharge, and in-hospital mor-
tality: a propensity score matched analysis. Reg Anesth Pain Med.
2014;39:381–386. doi:10.1097/AAP.0000000000000121
13. Chery J, Semaan E, Darji S, Briggs WT, Yarmush J, D’Ayala M.
Impact of regional versus general anesthesia on the clinical outcomes
of patients undergoing major lower extremity amputation. Ann Vasc
Surg. 2014;28:1149–1156. doi:10.1016/j.avsg.2013.07.033
14. Rodgers A, Walker N, Schung S, et al. Reduction of postoperative
mortality and morbidity with epidural or spinal anaesthesia: results
from overview of randomized trials. BMJ. 2000;321:1–12. doi:10.
1136/bmj.321.7252.1
15. Lin R, Hingorani A, Marks N, et al. Effects of anesthesia versus
regional nerve block on major leg amputation mortality rate.
Vascular. 2013;21(2):83–86. doi:10.1177/1708538113478718
Kim et al Dovepress
submit your manuscript | www.dovepress.com
DovePress
Therapeutics and Clinical Risk Management 2019:151170
16. Smith LM, Cozowicz C, Uda Y, Memtsoudis SG, Barrington MJ.
Neuraxial and combined neuraxial/general anesthesia compared to
general anesthesia for major truncal and lower limb surgery: a sys-
tematic review and meta-analysis. Anesth Analg. 2017;125:1931–
1945. doi:10.1213/ANE.0000000000002069
17. Urwin SC, Parker MJ, Grifﬁths R. General versus regional anaesthe-
sia for hip fracture surgery: a meta-analysis of randomized trials.
BJA. 2000;84(4):450–455. doi:10.1093/oxfordjournals.bja.a013468
18. Neuman MD, Silber JH, Elkassabany NM, Ludwig JM, Fleisher LA.
Comparative effectiveness of regional versus general anesthesia for
hip fracture surgery in adults. Anesthesiology. 2012;117(1):72–92.
doi:10.1097/ALN.0b013e3182545e7c
19. Memtsoudis SG, Sun X, Chiu Y-L, et al. Perioperative comparative
effectiveness of anesthetic technique in orthopedic patients.
Anesthesiology. 2013;118:1046–1058. doi:10.1097/ALN.0b013e3182860
61d
20. Helwani MA, Avidan MS, Abdallah AB, et al. Effects of regional
versus general anesthesia on outcomes after total hip arthroplasty. J
Bone Joint Surg Am. 2015;97:186–193. doi:10.2106/JBJS.N.00612
21. Khan SA, Qianyi RL, Liu C, Ng EL, Fook-Chong S, Tan MGE.
Effect of anaesthetic technique on mortality following major lower
extremity amputation: a propensity score-matched observational
study. Anaesthesia. 2013;68:612–620. doi:10.1111/anae.12182
22. Moreira CC, Farber A, Kalish JA, et al. The effect of anesthesia type
on major lower extremity amputation in functionally impaired elderly
patients. J Vasc Surg. 2016;63:696–701. doi:10.1016/j.jvs.2015.09.
050
23. Pisansky AJB, Brovman EY, Kuo C, Kaye AD, Urman RD.
Perioperative outcomes after regional versus general anesthesia for
above the knee amputations. Ann Vasc Surg. 2018;48:53–66. doi:10.
1016/j.avsg.2017.10.014
24. Gurney JK, Stanley J, Rumball-Smith J, York S, Sarfati D.
Postoperative death after lower-limb amputation in a national preva-
lent cohort of patients with diabetes. Diabetes Care. 2018;41:1204–
1211. doi:10.2337/dc17-2557
Therapeutics and Clinical Risk Management Dovepress
Publish your work in this journal
Therapeutics and Clinical Risk Management is an international, peer-
reviewed journal of clinical therapeutics and risk management, focusing
on concise rapid reporting of clinical studies in all therapeutic areas,
outcomes, safety, and programs for the effective, safe, and sustained
use of medicines. This journal is indexed on PubMed Central, CAS,
EMBase, Scopus and the Elsevier Bibliographic databases. The
manuscript management system is completely online and includes
a very quick and fair peer-review system, which is all easy to use.
Visit http://www.dovepress.com/testimonials.php to read real quotes
from published authors.
Submit your manuscript here: https://www.dovepress.com/therapeutics-and-clinical-risk-management-journal
Dovepress Kim et al
Therapeutics and Clinical Risk Management 2019:15 submit your manuscript | www.dovepress.com
DovePress
1171
